Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.

S. Alavian | M. Manns | Chien-Jen Chen | H. Poustchi | M. Blachier | H. Leleu | R. Marinho | S. Olafsson | J. Jónasson | F. Sanai | F. Roudot-thoraval | F. Negro | R. Idilman | C. Stedman | L. Roberts | J. Kao | T. Su | M. Yuen | A. Hatzakis | H. Razavi | S. Hamid | V. Saraswat | Samir R. Shah | G. Shiha | S. Tan | H. Chan | R. Mohamed | G. Dore | D. Struck | R. Stauber | D. Lavanchy | S. Zeuzem | C. Sarrazin | W. Laleman | S. Merat | M. Choi | G. Ergör | U. Akarca | S. Mauss | H. Wedemeyer | D. Kershenobich | I. Waked | G. Esmat | W. Rosenberg | I. Tolmane | W. Vogel | A. Assiri | P. Marotta | K. Peltekian | B. Müllhaupt | E. Gane | N. Janjua | J. Grebely | V. Arendt | B. Hunyady | J. Valantinas | R. Chien | S. Norris | R. Flisiak | E. Zuckerman | P. Arkkila | E. Yunihastuti | R. Phillips | W. Jafri | J. Tanaka | H. Vlierberghe | K. Souliotis | H. Krarup | R. Njouom | O. Opare-Sem | Y. Lim | H. Reesink | A. Vince | Christophe Moreno | A. Craxì | R. Safadi | N. Méndez-Sánchez | S. Roberts | P. Stärkel | H. Al-Romaihi | V. Sypsa | M. Pessoa | F. Bihl | F. Bessone | M. Gschwantler | A. Goldiş | P. Bruggmann | K. Falconer | M. Krajden | M. Makara | B. Hajarizadeh | M. El-Sayed | G. Papatheodoridis | W. Chuang | H. Qureshi | N. Prabdial-Sing | A. Sharara | E. Croes | V. Liakina | P. Jarčuška | P. Damme | W. Sievert | C. Brunton | S. Ryder | P. Lázaro | C. Bergin | A. Bane | S. Kaymakoğlu | Michael Li | M. Maimets | C. Seguin-Devaux | V. Chulanov | V. Ledinghen | O. Dalgard | Z. Ben‐Ari | A. Yosry | M. Memon | A. Ramji | Faryal Al Lawati | Khalid Al Namaani | Said A. Al-Busafi | K. Tomasiewicz | J. García-Samaniego | D. Muljono | A. Bizri | F. Abaalkhail | C. Estes | J. Daruich | I. Gamkrelidze | E. Ridruejo | P. Christensen | N. Weis | L. A. Lesmana | A. Thompson | H. Hofer | A. Rached | M. Clausen | J. Khamis | S. Aleman | M. L. Ferraz | M. Gottfredsson | W. Lao | H. Cheinquer | M. Cramp | A. Alghamdi | I. Altraif | K. Razavi-Shearer | F. Mourad | R. Jahis | J. Sperl | A. Blasco | A. Mahomed | Y. Kamel | S. Oguche | I. Hrstic | Manik Sharma | R. Salupere | C. Mello | S. Blach | R. Sarmento-Castro | M. Andersson | O. Lesi | D. Nonković | B. Lukšić | A. Metwally | S. Robbins | J. Ávila | O. Sagalova | A. Aljumah | W. Hamoudi | I. Aho | M. Sonderup | S. Himatt | L. Kondili | O. Baatarkhuu | L. Cisneros | M. Oltman | T. Oyunsuren | N. Pimenov | I. Schreter | A. Shevaldin | Aasim Yusuf | I. Gountas | Y. Hui | C. Yaghi | J. Schmelzer | M. Lai | A. Malu | A. Øvrehus | E. Farag | J. Gunter | O. Hajelssedig | K. Murphy | H. Nde | S. Obekpa | O. Omede | C. Omuemu | B. Redae | A. Abdou | A. Jēruma | Z. Koutoubi | D. Speičienė | F. Calinas | P. Ferreira | I. Thiel | V. Wong | S. Kaabi | A. Chaudhry | M. Correa | Layla Al-Dabal | A. Khan | Young Sik Kim | K. Pasini | S. Owusu-Ofori | Mei‐Hsuan Lee | I. Ghazzawi | Maheeba Abdulla | S. Fraňková | A. J. Meer | Y. A. Serkal | D. Razavi‐Shearer | Ann-Sofi Duberg | I. Schréter | V. Chulanov

[1]  A. Törner,et al.  The underreporting of hepatocellular carcinoma to the cancer register and a log‐linear model to estimate a more correct incidence , 2017, Hepatology.

[2]  T. Ayer,et al.  Hepatitis C Disease Burden in the United States in the era of oral direct‐acting antivirals , 2016, Hepatology.

[3]  Reza Assadi,et al.  The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 , 2016, The Lancet.

[4]  M. Stepanova,et al.  Association of work productivity with clinical and patient‐reported factors in patients infected with hepatitis C virus , 2016, Journal of viral hepatitis.

[5]  S. Alavian,et al.  Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden , 2016, Hepatitis monthly.

[6]  S. Roberts,et al.  Systematic review: current concepts and challenges for the direct‐acting antiviral era in hepatitis C cirrhosis , 2016, Alimentary pharmacology & therapeutics.

[7]  M. Stepanova,et al.  Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden. , 2016, Gastroenterology.

[8]  P. Gow,et al.  Novel population‐based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed , 2016, Hepatology.

[9]  M. Buti,et al.  Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH‐C) patients: an economic model from five European countries , 2016, Journal of viral hepatitis.

[10]  R. Malekzadeh,et al.  Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3 , 2015, Journal of viral hepatitis.

[11]  R. Malekzadeh,et al.  Strategies to manage hepatitis C virus infection disease burden – volume 3 , 2015, Journal of viral hepatitis.

[12]  M. Manns,et al.  Extrahepatic morbidity and mortality of chronic hepatitis C. , 2015, Gastroenterology.

[13]  M. Stepanova,et al.  Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States , 2015, Hepatology.

[14]  C. Destache,et al.  Hepatitis C therapy: Looking toward interferon-sparing regimens. , 2015, Journal of the American Pharmacists Association : JAPhA.

[15]  R. Mao,et al.  Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China , 2015, Journal of viral hepatitis.

[16]  H. Razavi,et al.  Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.

[17]  A. Flaxman,et al.  Global Distribution and Prevalence of Hepatitis C Virus Genotypes , 2014, Hepatology.

[18]  G. Esmat,et al.  The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm , 2014, Journal of viral hepatitis.

[19]  J. Feld,et al.  Acute Hepatitis C: Management in the Rapidly Evolving World of HCV , 2014, Current Gastroenterology Reports.

[20]  A. Flaxman,et al.  Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.

[21]  Chien-Jen Chen,et al.  Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. , 2012, The Journal of infectious diseases.

[22]  Weizhong Yang,et al.  [A sero-epidemiological study on hepatitis C in China]. , 2011, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[23]  D. Lavanchy.  Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  D. Lavanchy.  The global burden of hepatitis C , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[25]  D. Malcolm,et al.  Application of a Technique for Research and Development Program Evaluation , 1959 .